Katja Deterding

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective

Jerzy Jaroszewicz, Beatriz Calle Serrano, Karsten Wursthorn et al. · Journal of Hepatology · 2010 · 399 citations

Hepatitis D, Vaccination, Hepatology +10

Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues

Florian van Bömmel, Robert A. de Man, Heiner Wedemeyer et al. · Hepatology · 2009 · 330 citations

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

P. Arends, Milan J. Sonneveld, Roeland Zoutendijk et al. · Gut · 2014 · 205 citations · Full text

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis

Roeland Zoutendijk, Jurriën G.P. Reijnders, Fabien Zoulim et al. · Gut · 2012 · 186 citations

Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naïve patients with a partial virological response

Roeland Zoutendijk, Jurriën G.P. Reijnders, Ashley Brown et al. · Hepatology · 2011 · 171 citations · Full text